Nasdaq
ACRS
Aclaris Therapeutics, Inc.
- Health Care
- Listed 2015
- 1 day
- −4.2%
- 1 month
- +8.4%
- 1 year
- +293%
$6.09 · Mkt cap $851M
At the 6 Aug 2026 close
Nasdaq
Aclaris Therapeutics, Inc.
$6.09 · Mkt cap $851M
At the 6 Aug 2026 close
Aclaris Therapeutics, Inc. trades under the ticker ACRS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2015. Its market capitalisation is $851M. The last closing price was $6.09, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +293%, and +8.4% over the past month. Returns are price returns and exclude dividends.
This page exists because ACRS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.